Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia Infections

Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia Infections

Abstract Introduction Stenotrophomonas maltophilia is notable for its rising incidence and multidrug resistance, which complicates treatment. As a result of insufficient clinical studies, the 2024 Infectious Diseases Society of America (IDSA) Guidance on Treating Antimicrobial Resistant Gram-negativ...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammed Al Musawa, Ashlan J. Kunz Coyne, Sara Alosaimy, Kristen Lucas, Melanie Rae Schrack, Justin Andrade, Shelbye R. Herbin, Mark Biagi, Michael Pierce, Kyle C. Molina, Nicholson B. Perkins, Reese Cosimi, Lena Kang-Birken, Madeline A. King, Benjamin M. Pullinger, Leonor M. Rojas, Jeannette Bouchard, Athena L. V. Hobbs, Jazmin Agee, Kaylee E. Caniff, Sean R. Van Helden, Michael P. Veve, Michael J. Rybak
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-06-01
Series:Infectious Diseases and Therapy
Subjects:
Antimicrobial resistance
Drug resistance
Eravacycline
Gram-negative
Stenotrophomonas maltophilia
Online Access:https://doi.org/10.1007/s40121-025-01170-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s40121-025-01170-x

Similar Items